Table 1.
Antiviral activity and cytotoxicity of zinc ejectors
Compound | EC50 (µM) | CC50 (µM) | Therapeutic index | References |
---|---|---|---|---|
NOBA | ND | 10.6 | − | Huang et al. (1998) |
DIBA-1 | 2.3 | >200 | >87 | Huang et al. (1998), Rice et al. (1995) |
Dithiane | 6.6 | 184 | 30 | Huang et al. (1998) |
ADA | 38 | >200 | >5 | Huang et al. (1998), Rice et al. (1997a, b) |
PATE-45 | 6.2 | >316 | >51 | Turpin et al. (1999) |
SAMT-19 | 2.9 | 461 | 160 | Srivastava et al. (2004) |
NV038 | 17 | >300 | >17 | Pannecouque et al. (2010) |
WDO-217 | 7.9 | 72 | 9 | Vercruysse et al. (2012) |
[SP-4-2]-[PtCl(NH3)(quin)(9-EtGH)] | 41.9 | >200 | >4.75 | Sartori et al. (2000) |
EC50, 50 % effective concentration (concentration of inhibitor for 50 % inhibition of viral replication); CC50, 50 % cytotoxic concentration (concentration of inhibitor that kills 50 % of cells), Therapeutic index = CC50/EC50. ND, not determined